Medtronic, Inc. (NYSE:MDT) issued an updated statement on the recent ruling by Federal District Court of Delaware. The ruling granted in part Edwards Lifesciences’ motion for a preliminary injunction that prevents Medtronic from selling or offering to sell its CoreValve® System in the United States, except through a mechanism that Medtronic is pursuing with Edwards Lifesciences that would allow currently trained sites to treat patients with CoreValve based on a physician’s medical judgment. The injunction will go into effect on April 23. Medtronic, Inc. (NYSE:MDT) shares after opening at $58.36 moved to $59.24 on last trade day and at the end of the day closed at $58.55. Company price to sales ratio in past twelve months was calculated as 3.47 and price to cash ratio as 4.29. Medtronic, Inc. (NYSE:MDT) showed a negative weekly performance of -2.58%.
Fifteen months after splitting off from Abbott Laboratories, AbbVie Inc. (NYSE:ABBV) is taking its first steps off its former parent’s sprawling north suburban campus. AbbVie Inc (NYSE:ABBV) shares advanced 0.89% in last trading session and ended the day on $48.55. ABBV return on equity ratio is recorded as 113.20% and its return on assets is 14.70%. AbbVie Inc (NYSE:ABBV) yearly performance is 18.79%.
Bristol-Myers Squibb Co (NYSE:BMY) said that it has filed a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval of a combination that combines its HIV treatment vaccine called Reyataz whose chemical name is Atazanavir Sulfate and Gilead Sciences, Inc. (NASDAQ:GILD) Cobicistat for treating the HIV virus. Bristol-Myers Squibb Co (NYSE:BMY) shares moved up 0.71% in last trading session and was closed at $49.46 while trading in range of $48.95 – $49.68 – Bristol-Myers Squibb Co (NYSE:BMY) year to date (YTD) performance is -6.29%.
New York financial regulators report an agreement with Aetna Inc (NYSE:AET) Life Insurance Co. to pay $500,000 for using group life insurance policy forms that didn’t include required information notifying policyholders of certain rights and benefits. Aetna Inc (NYSE:AET) weekly performance is -5.70%. On last trading day company shares ended up $67.77. Aetna Inc (NYSE:AET) distance from 50-day simple moving average (SMA50) is -5.51%. Analysts mean target price for the company is $80.78.
Leave a Reply